Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$69.79 - $100.33 $877,330 - $1.26 Million
-12,571 Reduced 16.89%
61,848 $4.55 Million
Q4 2022

Feb 14, 2023

SELL
$80.12 - $105.34 $310,224 - $407,876
-3,872 Reduced 4.95%
74,419 $6.22 Million
Q3 2022

Nov 14, 2022

BUY
$96.79 - $131.14 $697,662 - $945,257
7,208 Added 10.14%
78,291 $7.58 Million
Q2 2022

Aug 12, 2022

BUY
$105.12 - $173.85 $1.83 Million - $3.03 Million
17,403 Added 32.42%
71,083 $7.47 Million
Q1 2022

May 16, 2022

SELL
$124.79 - $178.09 $1.23 Million - $1.76 Million
-9,878 Reduced 15.54%
53,680 $9.25 Million
Q4 2021

Feb 14, 2022

BUY
$136.32 - $184.41 $1.77 Million - $2.4 Million
13,020 Added 25.76%
63,558 $10.3 Million
Q3 2021

Nov 15, 2021

BUY
$149.1 - $270.32 $6.05 Million - $11 Million
40,580 Added 407.51%
50,538 $7.54 Million
Q2 2021

Aug 16, 2021

BUY
$238.97 - $288.5 $2.38 Million - $2.87 Million
9,958 New
9,958 $2.44 Million

Others Institutions Holding AMED

About AMEDISYS INC


  • Ticker AMED
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 32,492,000
  • Market Cap $2.74B
  • Description
  • Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal...
More about AMED
Track This Portfolio

Track Advantage Alpha Capital Partners LP Portfolio

Follow Advantage Alpha Capital Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advantage Alpha Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Advantage Alpha Capital Partners LP with notifications on news.